|
| 37864829 | Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD. | J Crohns Colitis | 2024 |
| 38069472 | Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies. | J Crohns Colitis | 2024 |
| 37952114 | The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study. | J Crohns Colitis | 2024 |
| 35123095 | Early Biologic Initiation After Chronic Pouch Inflammation Diagnosis Does Not Impact Clinical Outcomes. | Clin Gastroenterol Hepatol | 2023 |
| 36109152 | Biopsy and blood-based molecular biomarker of inflammation in IBD. | Gut | 2023 |
| 36306530 | Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children: Expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric Committee. | Journal of Pediatric Gastroenterology and Nutrition | 2023 |
| 36242764 | Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. | Inflammatory Bowel Diseases | 2023 |
| 35590456 | High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course. | Inflamm Bowel Dis | 2023 |
| 35830416 | Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2023 |
| 36351035 | Evaluating lleal Pouch Anal Anastomosis Function: Time to Expand Our ARM-amentarium. | Inflammatory Bowel Diseases | 2023 |
| 35380664 | Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program. | Inflamm Bowel Dis | 2023 |
| 35436497 | Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease. | Gastroenterology | 2023 |
| 36280102 | Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab. | Clin Gastroenterol Hepatol | 2023 |
| 36271912 | Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain. | | 2023 |
| 36064828 | A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease. | Digestive Diseases and Sciences | 2023 |
| 36377259 | Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. | Aliment Pharmacol Ther | 2023 |
| 36114773 | Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease. | Am J Gastroenterol | 2023 |
| 38043686 | Ketorolac for postpartum pain management in patients with inflammatory bowel disease. | | 2023 |
| 37789059 | Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards. | Nat Rev Gastroenterol Hepatol | 2023 |
| 37771797 | Targeting Cytokines in Inflammatory Bowel Disease. | | 2023 |
| 36777368 | Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission. | | 2023 |
| 36940447 | Guide to Intestinal Ultrasound Credentialing, Documentation, and Billing for Gastroenterologists in the United States. | | 2023 |
| 36624036 | Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH Trial. | | 2023 |
| 36937140 | The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease. | Crohns Colitis 360 | 2023 |
| 36745039 | Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States. | Inflamm Bowel Dis | 2023 |
| 36738443 | Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions. | J Crohns Colitis | 2023 |
| 36464141 | Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment. | Clin Gastroenterol Hepatol | 2023 |
| 37543407 | The Past, Present, and Future of Pediatric Inflammatory Bowel Disease. | | 2023 |
| 37482173 | High Use of Estrogen-based Contraceptives in Young Women With Inflammatory Bowel Disease in the United States. | | 2023 |
| 34871388 | Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. | Inflamm Bowel Dis | 2022 |
| 35390140 | Outcomes of Children with Inflammatory Bowel Disease who Develop Anti-tumour Necrosis Factor-induced Skin Reactions. | | 2022 |
| 35644154 | Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. | Lancet | 2022 |
| 35644155 | Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial. | Lancet | 2022 |
| 35579797 | Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy-Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring. | Digestive Diseases and Sciences | 2022 |
| 36082341 | Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry. | Crohn's and Colitis 360 | 2022 |
| 35552413 | Vitamin D Deficiency is Common in Patients with Ulcerative Colitis After Total Proctocolectomy with Ileal Pouch Anal Anastomosis. | Inflammatory Bowel Diseases | 2022 |
| 35365535 | Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial). | BMJ Open | 2022 |
| 36067818 | The Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index: A Step Forward for Transmural Pediatric Crohn's Disease Monitoring and Healing. | Gastroenterology | 2022 |
| 35993338 | Review article: guide to tofacitinib dosing in patients with ulcerative colitis. | Alimentary Pharmacology and Therapeutics | 2022 |
| 35362902 | Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults. | Journal of Patient-Reported Outcomes | 2022 |
| 35788348 | CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. | Gastroenterology | 2022 |
| 35464812 | Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol. | Therapeutic Advances in Musculoskeletal Disease | 2022 |
| 36513478 | Feasibility and impact of a quality improvement initiative to screen for malnutrition in an Inflammatory Bowel Disease clinic. | Clin Nutr ESPEN | 2022 |
| 36777426 | Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis. | Crohns Colitis 360 | 2022 |
| 34115661 | Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD. | J Clin Gastroenterol | 2022 |
| 34272560 | Peripartum Exposure to Biologic Therapy Does Not Impact Postpartum Wound Healing in Women With IBD. | Inflammatory Bowel Diseases | 2022 |
| 33827316 | Improved Smoking Cessation Rates in a Pharmacist-Led Program Embedded in an Inflammatory Bowel Disease Specialty Medical Home. | J Pharm Pract | 2022 |
| 34033922 | Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability. | Clin Gastroenterol Hepatol | 2022 |
| 34021427 | Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab. | Digestive Diseases and Sciences | 2022 |
| 34798332 | Resilience-based Integrated IBD Care Is Associated With Reductions in Health Care Use and Opioids. | Clinical Gastroenterology and Hepatology | 2022 |